Studies have found that elevated KCNC2 might be implicated in the maturation of neuronal electrical activity during nervous system development, and a decrease in KCNC2 may aggravate the impairment of cognitive function in AD patients (Boda et al., 2012). The gene discussed is KCNC2; the disease is Alzheimer disease.